Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Nicolette Charles A. | Chief Scientific Officer | 19 | $32.3K | $46.8K | 2018-04-25 |
| Abbey Jeffrey D | President, CEO | 25 | $59.1K | $76.7K | 2018-04-25 |
| Harrelson Lori R. | Vice President of Finance | 12 | $0 | $30.0K | 2018-04-25 |
| Katz Richard D | Vice President and CFO | 9 | $0 | $49.6K | 2018-04-25 |
| Pharmstandard International S.A. | 10% Owner | 9 | $852.4K | $0 | 2017-10-31 |
| MORRISON RICHARD G | Director | 1 | $0 | $0 | 2017-09-26 |
| Public Joint Stock Co Pharmstandard | 10% Owner | 20 | $11.32M | $0 | 2017-06-21 |
| Krol Igor | Director | 5 | $0 | $0 | 2017-01-19 |
| Carey Robert | Director | 6 | $0 | $0 | 2017-01-19 |
| Winterbottom Joan | Chief Human Resources Officer | 13 | $7.1K | $0 | 2017-01-19 |
| van Deventer Sander | Director, 10% Owner | 18 | $291.3K | $0 | 2017-01-19 |
| ALLEN LEE F MD PhD | Chief Medical Officer | 5 | $0 | $0 | 2017-01-19 |
| Birner Hubert | Director, 10% Owner | 20 | $319.0K | $0 | 2017-01-19 |
| Mtibelishvily Irackly | Director | 2 | $0 | $0 | 2016-12-31 |
| SNYDERMAN RALPH | Director | 2 | $0 | $0 | 2016-12-31 |
| Van Holle Philippe Marie Marcel Joseph | Director | 13 | $234.4K | $0 | 2016-09-30 |
| Petrov Andrei Vladimirovich | Director, 10% Owner | 6 | $9.0K | $0 | 2016-09-30 |
| ForArgos B.V. | 10% Owner | 4 | $0 | $0 | 2016-08-02 |
| Vinogradov Alexey Alexandrovich | Director, 10% Owner | 4 | $4.3K | $0 | 2016-03-31 |
| MIESOWICZ FREDERICK | COO | 9 | $0 | $0 | 2016-01-08 |
| Lamarre Jean | Director | 2 | $15.3K | $0 | 2015-08-25 |
| Plessinger Douglas C. | See Remarks | 2 | $0 | $0 | 2015-06-17 |
| Underdown Brian J. | Director, 10% Owner | 11 | $324.0K | $0 | 2015-06-17 |
| Forbion Co-Investment II Cooperatief U.A. | 10% Owner | 5 | $291.3K | $0 | 2014-02-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Nicolette Charles A. | CSO and Vice President of R& | D To issuer | 2018-04-25 | 2018-04-25 | 27,150 | — | $0 | 20,056 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | D To issuer | 2018-04-25 | 2018-04-25 | 22,629 | — | $0 | 11,776 | SEC↗ |
| Katz Richard D | Vice President and CFO | D To issuer | 2018-04-25 | 2018-04-25 | 22,629 | — | $0 | 9,697 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | D To issuer | 2018-04-25 | 2018-04-25 | 67,887 | — | $0 | 25,450 | SEC↗ |
| Katz Richard D | Vice President and CFO | A Award | 2018-03-28 | 2018-04-02 | 22,629 | — | $0 | 32,326 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award | 2018-03-28 | 2018-03-30 | 67,887 | — | $0 | 93,337 | SEC↗ |
| Nicolette Charles A. | CSO and Vice President of R& | A Award | 2018-03-28 | 2018-03-30 | 27,150 | — | $0 | 47,206 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | A Award | 2018-03-28 | 2018-03-30 | 22,629 | — | $0 | 34,405 | SEC↗ |
| Abbey Jeffrey D | President, CEO | S Sale | 2018-01-10 | 2018-01-12 | 124,987 | $0.16 | $20.0K | 510,046 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | S Sale | 2018-01-10 | 2018-01-12 | 64,329 | $0.16 | $10.3K | 230,981 | SEC↗ |
| Nicolette Charles A. | CSO and Vice President of R& | S Sale | 2018-01-10 | 2018-01-12 | 100,250 | $0.16 | $16.0K | 399,990 | SEC↗ |
| Katz Richard D | Vice President and CFO | S Sale | 2018-01-10 | 2018-01-12 | 104,435 | $0.16 | $16.7K | 193,959 | SEC↗ |
| Katz Richard D | Vice President and CFO | S Sale | 2018-01-09 | 2018-01-12 | 104,435 | $0.16 | $16.7K | 193,959 | SEC↗ |
| Abbey Jeffrey D | President, CEO | S Sale | 2018-01-09 | 2018-01-12 | 124,987 | $0.16 | $20.0K | 510,046 | SEC↗ |
| Nicolette Charles A. | CSO and Vice President of R& | S Sale | 2018-01-09 | 2018-01-12 | 100,250 | $0.16 | $16.0K | 399,990 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | S Sale | 2018-01-09 | 2018-01-12 | 64,329 | $0.16 | $10.3K | 230,981 | SEC↗ |
| Abbey Jeffrey D | President, CEO | S Sale | 2018-01-03 | 2018-01-05 | 114,702 | $0.16 | $18.4K | 635,033 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | S Sale | 2018-01-03 | 2018-01-05 | 59,072 | $0.16 | $9.5K | 295,310 | SEC↗ |
| Nicolette Charles A. | CSO and Vice President of R& | S Sale | 2018-01-03 | 2018-01-05 | 92,001 | $0.16 | $14.7K | 500,240 | SEC↗ |
| Katz Richard D | Vice President and CFO | S Sale | 2018-01-03 | 2018-01-05 | 101,228 | $0.16 | $16.2K | 298,394 | SEC↗ |
| Abbey Jeffrey D | President, CEO | S Sale | 2018-01-03 | 2018-01-05 | 114,702 | $0.16 | $18.4K | 635,033 | SEC↗ |
| Pharmstandard International S. | 10% Owner | J Other | 2017-10-31 | 2017-11-02 | 99,495 | $795.96 | $79.19M | 13,142,784 | SEC↗ |
| MORRISON RICHARD G | Director | A Award deriv | 2017-09-26 | 2017-09-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award | 2017-08-30 | 2017-08-31 | 622,685 | — | $0 | 749,735 | SEC↗ |
| Nicolette Charles A. | Chief Science Officer | A Award | 2017-08-30 | 2017-08-31 | 499,445 | — | $0 | 592,241 | SEC↗ |
| Katz Richard D | VP and Chief Financial Offic | A Award | 2017-08-30 | 2017-08-31 | 395,664 | — | $0 | 399,622 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | A Award | 2017-08-30 | 2017-08-31 | 320,683 | — | $0 | 354,382 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy deriv | 2017-06-21 | 2017-06-23 | 0 | — | $0 | 0 | SEC↗ |
| Harrelson Lori R. | Vice President Finance | A Award deriv | 2017-01-20 | 2017-01-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Harrelson Lori R. | Vice President Finance | A Award | 2017-01-20 | 2017-01-23 | 3,694 | — | $0 | 33,699 | SEC↗ |
| Carey Robert | Director | A Award deriv | 2017-01-19 | 2017-01-20 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Birner Hubert | Director | A Award deriv | 2017-01-19 | 2017-01-20 | 9,500 | — | $0 | 9,500 | SEC↗ |
| van Deventer Sander | Director | A Award deriv | 2017-01-19 | 2017-01-20 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Krol Igor | Director | A Award deriv | 2017-01-19 | 2017-01-20 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Nicolette Charles A. | Chief Science Officer | A Award deriv | 2017-01-19 | 2017-01-23 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award deriv | 2017-01-19 | 2017-01-23 | 386,212 | — | $0 | 386,212 | SEC↗ |
| ALLEN LEE F MD PhD | Chief Medical Officer | A Award deriv | 2017-01-19 | 2017-01-23 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Katz Richard D | VP & Chief Financial Officer | A Award deriv | 2017-01-19 | 2017-01-23 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | A Award deriv | 2017-01-19 | 2017-01-23 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Nicolette Charles A. | Chief Science Officer | A Award | 2017-01-19 | 2017-01-23 | 16,753 | — | $0 | 92,796 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award | 2017-01-19 | 2017-01-23 | 17,430 | — | $0 | 127,050 | SEC↗ |
| ALLEN LEE F MD PhD | Chief Medical Officer | A Award | 2017-01-19 | 2017-01-23 | 7,378 | — | $0 | 7,378 | SEC↗ |
| Katz Richard D | VP & Chief Financial Officer | A Award | 2017-01-19 | 2017-01-23 | 3,958 | — | $0 | 3,958 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | A Award | 2017-01-19 | 2017-01-23 | 4,464 | — | $0 | 47,248 | SEC↗ |
| Birner Hubert | Director | A Award | 2016-12-31 | 2017-01-04 | 3,571 | — | $0 | 12,680 | SEC↗ |
| Mtibelishvily Irackly | Director | A Award | 2016-12-31 | 2017-01-04 | 395 | — | $0 | 14,895 | SEC↗ |
| Krol Igor | Director | A Award | 2016-12-31 | 2017-01-04 | 1,785 | — | $0 | 3,874 | SEC↗ |
| SNYDERMAN RALPH | Director | A Award | 2016-12-31 | 2017-01-04 | 573 | — | $0 | 573 | SEC↗ |
| Carey Robert | Director | A Award | 2016-12-31 | 2017-01-04 | 2,351 | — | $0 | 8,206 | SEC↗ |
| Mtibelishvily Irackly | Director | A Award deriv | 2016-12-13 | 2016-12-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SNYDERMAN RALPH | Director | A Award deriv | 2016-12-09 | 2016-12-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-10-07 | 2016-10-13 | 21,000 | $4.73 | $99.3K | 13,242,279 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-10-06 | 2016-10-13 | 2,640 | $4.81 | $12.7K | 13,221,279 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-10-05 | 2016-10-13 | 900 | $4.85 | $4.4K | 13,218,639 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-10-04 | 2016-10-13 | 7,164 | $4.69 | $33.6K | 13,217,739 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-10-03 | 2016-10-04 | 11,308 | $4.70 | $53.1K | 13,210,875 | SEC↗ |
| Birner Hubert | Director | A Award | 2016-09-30 | 2016-10-03 | 3,521 | — | $0 | 9,109 | SEC↗ |
| Petrov Andrei Vladimirovich | Director | A Award | 2016-09-30 | 2016-10-03 | 2,137 | — | $0 | 10,530 | SEC↗ |
| Krol Igor | Director | A Award | 2016-09-30 | 2016-10-03 | 1,760 | — | $0 | 2,089 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | A Award | 2016-09-30 | 2016-10-03 | 2,263 | — | $0 | 5,057 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | A Award | 2016-09-30 | 2016-10-03 | 2,263 | — | $0 | 50,955 | SEC↗ |
| Carey Robert | Director | A Award | 2016-09-30 | 2016-10-03 | 2,263 | — | $0 | 5,855 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-09-30 | 2016-10-04 | 30,232 | $4.71 | $142.4K | 13,199,567 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-09-29 | 2016-09-30 | 15,100 | $4.60 | $69.5K | 13,169,335 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-09-28 | 2016-09-30 | 28,518 | $4.54 | $129.5K | 13,154,235 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-09-20 | 2016-09-21 | 41,259 | $4.77 | $196.8K | 13,125,717 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-09-19 | 2016-09-21 | 5,580 | $4.76 | $26.6K | 13,084,458 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-09-16 | 2016-09-20 | 36,632 | $4.78 | $175.1K | 13,078,578 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-09-15 | 2016-09-20 | 15,880 | $4.76 | $75.6K | 13,041,946 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-09-01 | 2016-09-07 | 16,977 | $4.78 | $81.2K | 13,026,066 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-08-24 | 2016-08-25 | 57,772 | $4.55 | $262.9K | 12,953,865 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-08-24 | 2016-08-29 | 55,224 | $4.57 | $252.4K | 13,009,089 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-08-23 | 2016-08-25 | 9,599 | $4.36 | $41.9K | 12,896,093 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-08-22 | 2016-08-23 | 21,950 | $4.26 | $93.5K | 12,886,494 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-08-19 | 2016-08-23 | 53,524 | $4.23 | $226.4K | 12,864,544 | SEC↗ |
| ForArgos B.V. | 10% Owner | P Buy deriv | 2016-08-02 | 2016-08-04 | 1,159,090 | — | $0 | 1,159,090 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy deriv | 2016-08-02 | 2016-08-04 | 1,772,727 | — | $0 | 1,772,727 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy deriv | 2016-08-02 | 2016-08-04 | 1,159,090 | — | $0 | 1,159,090 | SEC↗ |
| ForArgos B.V. | 10% Owner | P Buy | 2016-08-02 | 2016-08-04 | 1,545,454 | — | $0 | 3,749,817 | SEC↗ |
| Pharmstandard International S. | 10% Owner | P Buy | 2016-08-02 | 2016-08-04 | 2,363,636 | — | $0 | 12,811,020 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy | 2016-08-02 | 2016-08-04 | 1,545,454 | — | $0 | 6,199,961 | SEC↗ |
| ALLEN LEE F MD PhD | Chief Medical Officer | A Award deriv | 2016-07-11 | 2016-07-12 | 83,373 | — | $0 | 83,373 | SEC↗ |
| Katz Richard D | VP & Chief Financial Officer | A Award deriv | 2016-07-11 | 2016-07-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Birner Hubert | Director | A Award | 2016-06-30 | 2016-07-05 | 2,854 | — | $0 | 5,588 | SEC↗ |
| Petrov Andrei Vladimirovich | Director | A Award | 2016-06-30 | 2016-07-05 | 1,733 | — | $0 | 8,393 | SEC↗ |
| Krol Igor | Director | A Award | 2016-06-30 | 2016-07-05 | 329 | — | $0 | 329 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | A Award | 2016-06-30 | 2016-07-05 | 1,427 | — | $0 | 2,794 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | A Award | 2016-06-30 | 2016-07-05 | 1,835 | — | $0 | 48,692 | SEC↗ |
| Carey Robert | Director | A Award | 2016-06-30 | 2016-07-05 | 1,835 | — | $0 | 3,592 | SEC↗ |
| ForArgos B.V. | 10% Owner | P Buy deriv | 2016-06-29 | 2016-07-01 | 991,964 | — | $0 | 991,964 | SEC↗ |
| Birner Hubert | Director | P Buy deriv | 2016-06-29 | 2016-07-01 | 206,659 | — | $0 | 206,659 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy deriv | 2016-06-29 | 2016-07-01 | 991,964 | — | $0 | 991,964 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy deriv | 2016-06-29 | 2016-07-01 | 2,008,726 | — | $0 | 2,008,726 | SEC↗ |
| ForArgos B.V. | 10% Owner | P Buy | 2016-06-29 | 2016-07-01 | 1,322,618 | — | $0 | 2,204,363 | SEC↗ |
| Birner Hubert | Director | P Buy | 2016-06-29 | 2016-07-01 | 275,545 | — | $0 | 1,930,333 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy | 2016-06-29 | 2016-07-01 | 1,322,618 | — | $0 | 4,654,507 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-06-29 | 2016-07-01 | 2,678,301 | — | $0 | 10,447,384 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | A Award deriv | 2016-06-13 | 2016-06-14 | 5,500 | — | $0 | 5,500 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | A Award deriv | 2016-06-13 | 2016-06-14 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Petrov Andrei Vladimirovich | Director, 10% Owner | A Award deriv | 2016-06-13 | 2016-06-14 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Nicolette Charles A. | Chief Scientific Officer | A Award deriv | 2016-06-13 | 2016-06-14 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Carey Robert | Director | A Award deriv | 2016-06-13 | 2016-06-14 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Birner Hubert | Director | A Award deriv | 2016-06-13 | 2016-06-14 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award deriv | 2016-06-13 | 2016-06-15 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | A Award deriv | 2016-06-13 | 2016-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Winterbottom Joan | Chief Human Resource Officer | A Award deriv | 2016-06-13 | 2016-06-15 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Nicolette Charles A. | Chief Scientific Officer | A Award | 2016-06-13 | 2016-06-14 | 10,924 | — | $0 | 76,043 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award | 2016-06-13 | 2016-06-15 | 10,924 | — | $0 | 109,620 | SEC↗ |
| Winterbottom Joan | Chief Human Resource Officer | A Award | 2016-06-13 | 2016-06-15 | 7,287 | — | $0 | 40,996 | SEC↗ |
| Winterbottom Joan | Chief Human Resource Officer | A Award | 2016-06-13 | 2016-06-15 | 9,075 | — | $0 | 42,784 | SEC↗ |
| Krol Igor | Director | P Buy deriv | 2016-06-10 | 2016-06-14 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Nicolette Charles A. | Chief Scientific Officer | A Award deriv | 2016-06-10 | 2016-06-14 | 3,375 | — | $0 | 3,375 | SEC↗ |
| ALLEN LEE F MD PhD | Chief Medical Officer | A Award deriv | 2016-04-15 | 2016-04-19 | 16,628 | — | $0 | 16,628 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | A Award | 2016-03-31 | 2016-04-04 | 1,757 | — | $0 | 46,857 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | A Award | 2016-03-31 | 2016-04-04 | 1,367 | — | $0 | 1,367 | SEC↗ |
| Birner Hubert | Director | A Award | 2016-03-31 | 2016-04-04 | 2,734 | — | $0 | 2,734 | SEC↗ |
| Petrov Andrei Vladimirovich | Director, 10% Owner | A Award | 2016-03-31 | 2016-04-04 | 1,660 | — | $0 | 6,660 | SEC↗ |
| Vinogradov Alexey Alexandrovic | Director, 10% Owner | A Award | 2016-03-31 | 2016-04-04 | 1,367 | — | $0 | 3,367 | SEC↗ |
| Carey Robert | Director | A Award | 2016-03-31 | 2016-04-04 | 1,757 | — | $0 | 1,757 | SEC↗ |
| Birner Hubert | Director | P Buy deriv | 2016-03-14 | 2016-03-16 | 137,773 | — | $0 | 137,773 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy deriv | 2016-03-14 | 2016-03-16 | 661,309 | — | $0 | 661,309 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy deriv | 2016-03-14 | 2016-03-16 | 1,339,151 | — | $0 | 1,339,151 | SEC↗ |
| Birner Hubert | Director | P Buy | 2016-03-14 | 2016-03-16 | 183,697 | — | $0 | 1,654,788 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy | 2016-03-14 | 2016-03-16 | 881,745 | — | $0 | 3,331,889 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2016-03-14 | 2016-03-16 | 1,785,534 | — | $0 | 7,769,083 | SEC↗ |
| ALLEN LEE F MD PhD | Chief Medical Officer | A Award deriv | 2016-01-19 | 2016-01-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | A Award | 2016-01-08 | 2016-01-12 | 28,125 | — | $0 | 30,005 | SEC↗ |
| Abbey Jeffrey D | CEO | A Award | 2016-01-08 | 2016-01-12 | 90,401 | — | $0 | 96,694 | SEC↗ |
| Nicolette Charles A. | Chief Scientific Officer | A Award | 2016-01-08 | 2016-01-12 | 48,604 | — | $0 | 63,117 | SEC↗ |
| Winterbottom Joan | Chief Human Resource Officer | A Award | 2016-01-08 | 2016-01-12 | 32,709 | — | $0 | 33,709 | SEC↗ |
| MIESOWICZ FREDERICK | COO | A Award | 2016-01-08 | 2016-01-12 | 35,554 | — | $0 | 36,843 | SEC↗ |
| Petrov Andrei Vladimirovich | Director | P Buy | 2015-12-16 | 2015-12-17 | 5,000 | $1.80 | $9.0K | 5,000 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy | 2015-12-16 | 2015-12-17 | 250 | $1.83 | $458 | 500 | SEC↗ |
| Vinogradov Alexey Alexandrovic | Director | P Buy | 2015-12-15 | 2015-12-16 | 2,000 | $2.15 | $4.3K | 2,000 | SEC↗ |
| Abbey Jeffrey D | CEO | P Buy | 2015-12-14 | 2016-01-08 | 5,000 | $2.50 | $12.5K | 11,500 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy | 2015-12-14 | 2015-12-16 | 50 | $2.15 | $108 | 250 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy | 2015-12-14 | 2015-12-16 | 100 | $2.15 | $215 | 100 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy | 2015-12-14 | 2015-12-16 | 100 | $2.15 | $215 | 200 | SEC↗ |
| Abbey Jeffrey D | CEO | P Buy | 2015-12-14 | 2015-12-17 | 5,000 | $2.50 | $12.5K | 10,500 | SEC↗ |
| Abbey Jeffrey D | CEO | P Buy | 2015-12-02 | 2015-12-03 | 1,000 | $3.89 | $3.9K | 6,293 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-11-24 | 2015-11-25 | 5,000 | $4.30 | $21.5K | 40,100 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-11-24 | 2015-11-25 | 5,000 | $4.25 | $21.3K | 45,100 | SEC↗ |
| Abbey Jeffrey D | CEO | P Buy | 2015-11-19 | 2015-11-23 | 1,000 | $4.08 | $4.1K | 6,500 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-11-19 | 2015-11-23 | 10,000 | $4.15 | $41.5K | 35,100 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy deriv | 2015-09-18 | 2015-09-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-09-03 | 2015-09-04 | 6,000 | $6.31 | $37.9K | 25,100 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-09-02 | 2015-09-04 | 6,000 | $6.22 | $37.3K | 19,100 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-09-01 | 2015-09-02 | 5,000 | $6.26 | $31.3K | 13,100 | SEC↗ |
| Lamarre Jean | Director | P Buy | 2015-08-25 | 2015-08-26 | 2,500 | $6.14 | $15.3K | 2,500 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy | 2015-08-24 | 2015-08-27 | 100 | $6.09 | $609 | 1,000 | SEC↗ |
| Winterbottom Joan | Chief Human Resources Office | P Buy | 2015-08-24 | 2015-08-27 | 900 | $6.10 | $5.5K | 900 | SEC↗ |
| Nicolette Charles A. | Chief Scientific Officer | P Buy | 2015-08-20 | 2015-08-27 | 5,000 | $6.45 | $32.3K | 13,130 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-08-20 | 2015-08-27 | 5,000 | $5.80 | $29.0K | 8,100 | SEC↗ |
| Abbey Jeffrey D | CEO | P Buy | 2015-08-19 | 2015-08-21 | 5,500 | $4.75 | $26.1K | 5,500 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | P Buy | 2015-08-19 | 2015-08-27 | 3,100 | $4.73 | $14.7K | 3,100 | SEC↗ |
| Underdown Brian J. | Director | A Award deriv | 2015-06-17 | 2015-06-18 | 5,500 | — | $0 | 16,500 | SEC↗ |
| Underdown Brian J. | Director | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Lamarre Jean | Director | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Petrov Andrei Vladimirovich | Director, 10% Owner | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Vinogradov Alexey Alexandrovic | Director, 10% Owner | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Birner Hubert | Director | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Plessinger Douglas C. | See Remarks | A Award deriv | 2015-06-17 | 2015-06-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | A Award deriv | 2015-06-17 | 2015-06-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award deriv | 2015-06-17 | 2015-06-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| MIESOWICZ FREDERICK | COO | A Award deriv | 2015-06-17 | 2015-06-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Nicolette Charles A. | CSO | A Award deriv | 2015-06-17 | 2015-06-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Van Holle Philippe Marie Marce | Director | A Award deriv | 2015-06-17 | 2015-06-19 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | A Award deriv | 2014-07-28 | 2014-07-30 | 58,400 | — | $0 | 687,960 | SEC↗ |
| Harrelson Lori R. | Vice President of Finance | A Award deriv | 2014-07-28 | 2014-07-30 | 10,200 | — | $0 | 128,239 | SEC↗ |
| MIESOWICZ FREDERICK | COO | A Award deriv | 2014-07-28 | 2014-07-30 | 10,200 | — | $0 | 185,075 | SEC↗ |
| Plessinger Douglas C. | See Remarks | A Award deriv | 2014-07-28 | 2014-07-30 | 10,200 | — | $0 | 185,076 | SEC↗ |
| Nicolette Charles A. | CSO | A Award deriv | 2014-07-28 | 2014-07-30 | 18,000 | — | $0 | 297,803 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | A Award deriv | 2014-03-20 | 2014-03-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Vinogradov Alexey Alexandrovic | Director | A Award deriv | 2014-03-20 | 2014-03-24 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 4,708,549 | — | $0 | 0 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 984,840 | — | $0 | 0 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 1,428,888 | — | $0 | 0 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 8,202 | — | $0 | 0 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 94,351 | — | $0 | 0 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 665,583 | — | $0 | 0 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 663,082 | — | $0 | 0 | SEC↗ |
| Forbion Co-Investment II Coope | 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 984,840 | — | $0 | 0 | SEC↗ |
| Forbion Co-Investment II Coope | 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 1,428,888 | — | $0 | 0 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 569,990 | — | $0 | 0 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 582,769 | — | $0 | 0 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 43,185 | — | $0 | 0 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion deriv | 2014-02-12 | 2014-02-12 | 13,131 | — | $0 | 0 | SEC↗ |
| Nicolette Charles A. | CSO | C Conversion deriv | 2014-02-12 | 2014-02-12 | 4,941 | — | $0 | 0 | SEC↗ |
| Nicolette Charles A. | CSO | C Conversion deriv | 2014-02-12 | 2014-02-12 | 1,859 | — | $0 | 0 | SEC↗ |
| MIESOWICZ FREDERICK | COO | C Conversion deriv | 2014-02-12 | 2014-02-12 | 37 | — | $0 | 0 | SEC↗ |
| MIESOWICZ FREDERICK | COO | C Conversion deriv | 2014-02-12 | 2014-02-12 | 4,941 | — | $0 | 0 | SEC↗ |
| MIESOWICZ FREDERICK | COO | C Conversion deriv | 2014-02-12 | 2014-02-12 | 619 | — | $0 | 0 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | C Conversion deriv | 2014-02-12 | 2014-02-12 | 1,267 | — | $0 | 0 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | C Conversion deriv | 2014-02-12 | 2014-02-12 | 1,238 | — | $0 | 0 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | C Conversion deriv | 2014-02-12 | 2014-02-12 | 75 | — | $0 | 0 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | P Buy | 2014-02-12 | 2014-02-12 | 1,275,000 | $8.00 | $10.20M | 5,983,549 | SEC↗ |
| Public Joint Stock Co Pharmsta | 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 4,708,549 | — | $0 | 4,708,549 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 984,840 | — | $0 | 984,840 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | P Buy | 2014-02-12 | 2014-02-12 | 36,416 | $8.00 | $291.3K | 2,450,144 | SEC↗ |
| van Deventer Sander | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 1,428,888 | — | $0 | 2,413,728 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 94,351 | — | $0 | 102,553 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 663,082 | — | $0 | 1,431,218 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 665,583 | — | $0 | 768,136 | SEC↗ |
| Birner Hubert | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 8,202 | — | $0 | 8,202 | SEC↗ |
| Birner Hubert | Director, 10% Owner | P Buy | 2014-02-12 | 2014-02-12 | 39,873 | $8.00 | $319.0K | 1,471,091 | SEC↗ |
| Forbion Co-Investment II Coope | 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 1,428,888 | — | $0 | 2,413,728 | SEC↗ |
| Forbion Co-Investment II Coope | 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 984,840 | — | $0 | 984,840 | SEC↗ |
| Forbion Co-Investment II Coope | 10% Owner | P Buy | 2014-02-12 | 2014-02-12 | 36,416 | $8.00 | $291.3K | 2,450,144 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 582,769 | — | $0 | 639,085 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 569,990 | — | $0 | 1,209,075 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | P Buy | 2014-02-12 | 2014-02-12 | 40,497 | $8.00 | $324.0K | 1,249,572 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 43,185 | — | $0 | 56,316 | SEC↗ |
| Underdown Brian J. | Director, 10% Owner | C Conversion | 2014-02-12 | 2014-02-12 | 13,131 | — | $0 | 13,131 | SEC↗ |
| Nicolette Charles A. | CSO | C Conversion | 2014-02-12 | 2014-02-12 | 1,859 | — | $0 | 6,800 | SEC↗ |
| Nicolette Charles A. | CSO | C Conversion | 2014-02-12 | 2014-02-12 | 4,941 | — | $0 | 4,941 | SEC↗ |
| MIESOWICZ FREDERICK | COO | C Conversion | 2014-02-12 | 2014-02-12 | 37 | — | $0 | 37 | SEC↗ |
| MIESOWICZ FREDERICK | COO | C Conversion | 2014-02-12 | 2014-02-12 | 4,941 | — | $0 | 5,597 | SEC↗ |
| MIESOWICZ FREDERICK | COO | C Conversion | 2014-02-12 | 2014-02-12 | 619 | — | $0 | 656 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | C Conversion | 2014-02-12 | 2014-02-12 | 1,267 | — | $0 | 2,580 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | C Conversion | 2014-02-12 | 2014-02-12 | 1,238 | — | $0 | 1,313 | SEC↗ |
| Abbey Jeffrey D | Chief Executive Officer | C Conversion | 2014-02-12 | 2014-02-12 | 75 | — | $0 | 75 | SEC↗ |